Jay Kranzler

Jay D.
Kranzler was the founder of Sequel Therapeutics, Inc., founded in 1992, where the title held was President & Chief Executive Officer.
Dr. Kranzler was the founder of Glytec Corp., founded in 1989, where the title held was President & Chief Executive Officer in 1990.
Dr. Kranzler was also the founder of Perception Neuroscience, Inc...
Dr. Kranzler was previously Chairman & Chief Executive Officer at Urica Therapeutics, Inc. since 2022.
Dr. Kranzler is Chief Executive Officer & Director at Regenovation, Inc. Dr. Kranzler is Chairman at Avenue Therapeutics, Inc. since 2023.
Dr. Kranzler is Director at Navitas Pharma, Inc. Dr. Kranzler is Director at ImmunoBrain Checkpoint Ltd. Dr. Kranzler is Chief Medical Officer & Director at Pastorus, Inc. Dr. Kranzler is Director at Baergic Bio, Inc. Former positions include Chairman & Chief Executive Officer at Cypress Bioscience, Inc. from 1996 to 2011.
Dr. Kranzler was President, Chief Executive Officer & Director at Cytel Corp.
from 1989 to 1995.
Dr. Kranzler was Chairman at MSI Methylation Sciences, Inc. Dr. Kranzler was Vice President & Head-External R&D Innovation at Pfizer Inc. Dr. Kranzler was Professor at the University of California San Diego.
Education includes a doctorate from Yale University and an undergraduate degree from Yeshiva University.